Share Price and Basic Stock Data
Last Updated: December 24, 2024, 8:33 pm
| PEG Ratio | 0.32 |
|---|
Competitors of Hemant Surgical Industries Ltd
| Stock Name | Market Cap | Current Price | High / Low | Stock P/E | Book Value | Dividend Yield | ROCE | ROE | Face Value |
|---|---|---|---|---|---|---|---|---|---|
| Hemant Surgical Industries Ltd | 134 Cr. | 128 | 225/115 | 14.8 | 55.6 | 0.00 % | 29.8 % | 25.0 % | 10.0 |
| Industry Average | 134.00 Cr | 128.00 | 14.80 | 55.60 | 0.00% | 29.80% | 25.00% | 10.00 |
Quarterly Result
| Month | Sep 2022 | Sep 2023 |
|---|---|---|
| Sales | 51 | 48 |
| Expenses | 47 | 44 |
| Operating Profit | 4 | 3 |
| OPM % | 8% | 7% |
| Other Income | 1 | 3 |
| Interest | 1 | 1 |
| Depreciation | 0 | 1 |
| Profit before tax | 4 | 5 |
| Tax % | 36% | 17% |
| Net Profit | 2 | 4 |
| EPS in Rs | 124.73 | 3.75 |
Last Updated: Unknown
Profit & Loss - Annual Report
Last Updated: Unknown
| Month | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 |
|---|---|---|---|---|---|---|
| Sales | 51 | 56 | 56 | 60 | 101 | 109 |
| Expenses | 48 | 53 | 53 | 57 | 95 | 98 |
| Operating Profit | 2 | 3 | 3 | 3 | 6 | 11 |
| OPM % | 5% | 5% | 5% | 5% | 6% | 10% |
| Other Income | 0 | 0 | 0 | 1 | 2 | 2 |
| Interest | 1 | 1 | 2 | 2 | 2 | 2 |
| Depreciation | 0 | 1 | 0 | 1 | 1 | 1 |
| Profit before tax | 1 | 1 | 1 | 1 | 6 | 10 |
| Tax % | 10% | 8% | 41% | 9% | 25% | 24% |
| Net Profit | 1 | 1 | 0 | 1 | 5 | 8 |
| EPS in Rs | 50.76 | 61.02 | 27.00 | 73.43 | 248.92 | 413.07 |
| Dividend Payout % | 0% | 0% | 0% | 0% | 0% | 0% |
YoY Net Profit Growth
| Year | 2018-2019 | 2019-2020 | 2021-2022 | 2022-2023 |
|---|---|---|---|---|
| YoY Net Profit Growth (%) | 0.00% | -100.00% | 400.00% | 60.00% |
| Change in YoY Net Profit Growth (%) | 0.00% | -100.00% | 500.00% | -340.00% |
Hemant Surgical Industries Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 4 years from 2018-2019 to 2022-2023.
Growth
| Compounded Sales Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | 14% |
| 3 Years: | 21% |
| TTM: | 1% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | 54% |
| 3 Years: | 93% |
| TTM: | -2% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| 1 Year: | -24% |
| Return on Equity | |
|---|---|
| 10 Years: | % |
| 5 Years: | 28% |
| 3 Years: | 32% |
| Last Year: | 25% |
Last Updated: Unknown
Balance Sheet
Last Updated: November 14, 2024, 11:33 pm
| Month | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|
| Equity Capital | 2 | 2 | 2 | 2 | 2 | 8 | 10 | 10 |
| Reserves | 5 | 6 | 5 | 8 | 11 | 16 | 44 | 48 |
| Borrowings | 9 | 11 | 14 | 14 | 10 | 7 | 7 | 14 |
| Other Liabilities | 12 | 14 | 23 | 15 | 32 | 34 | 35 | 43 |
| Total Liabilities | 28 | 33 | 44 | 40 | 54 | 65 | 97 | 116 |
| Fixed Assets | 7 | 8 | 10 | 11 | 12 | 13 | 18 | 33 |
| CWIP | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments | 0 | 0 | 1 | 0 | 1 | 0 | 5 | 0 |
| Other Assets | 21 | 25 | 33 | 29 | 42 | 51 | 74 | 83 |
| Total Assets | 28 | 33 | 44 | 40 | 54 | 65 | 97 | 116 |
Cash Flow
| Month | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 |
|---|---|---|---|---|---|---|---|
Free Cash Flow
| Month | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 |
|---|---|---|---|---|---|---|
| Free Cash Flow | -7.00 | -8.00 | -11.00 | -11.00 | -4.00 | 4.00 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
| Month | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 |
|---|---|---|---|---|---|---|---|
| Debtor Days | 35 | 36 | 35 | 26 | 56 | 58 | 75 |
| Inventory Days | 64 | 73 | 125 | 113 | 57 | 67 | 99 |
| Days Payable | 102 | 97 | 143 | 89 | 92 | 110 | 116 |
| Cash Conversion Cycle | -3 | 12 | 17 | 51 | 21 | 15 | 58 |
| Working Capital Days | 12 | 23 | 14 | 66 | 2 | 16 | 74 |
| ROCE % | 15% | 12% | 14% | 32% | 45% | 30% |
This stock is not held by any mutual fund
Key Financial Ratios
| Month | Mar 24 | Mar 23 | Mar 22 | Mar 21 | Mar 20 |
|---|---|---|---|---|---|
| FaceValue | 10.00 | 10.00 | 10.00 | 10.00 | 100.00 |
| Basic EPS (Rs.) | 9.85 | 10.28 | 8.96 | 2.22 | 32.90 |
| Diluted EPS (Rs.) | 9.85 | 10.28 | 8.96 | 2.22 | 32.90 |
| Cash EPS (Rs.) | 10.37 | 11.07 | 26.81 | 8.90 | 73.82 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 52.55 | 30.73 | 65.74 | 42.67 | 400.80 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 52.55 | 30.73 | 65.74 | 42.67 | 400.80 |
| Revenue From Operations / Share (Rs.) | 101.16 | 142.12 | 517.85 | 298.82 | 2805.11 |
| PBDIT / Share (Rs.) | 14.16 | 16.69 | 42.50 | 19.81 | 150.54 |
| PBIT / Share (Rs.) | 13.17 | 15.59 | 38.76 | 16.64 | 119.62 |
| PBT / Share (Rs.) | 12.24 | 13.10 | 30.56 | 7.60 | 47.90 |
| Net Profit / Share (Rs.) | 9.39 | 9.96 | 23.07 | 5.73 | 42.90 |
| PBDIT Margin (%) | 13.99 | 11.74 | 8.20 | 6.62 | 5.36 |
| PBIT Margin (%) | 13.02 | 10.96 | 7.48 | 5.56 | 4.26 |
| PBT Margin (%) | 12.10 | 9.21 | 5.90 | 2.54 | 1.70 |
| Net Profit Margin (%) | 9.27 | 7.00 | 4.45 | 1.91 | 1.52 |
| Return on Networth / Equity (%) | 17.86 | 32.42 | 35.09 | 13.42 | 10.70 |
| Return on Capital Employeed (%) | 23.37 | 44.37 | 44.51 | 16.47 | 14.29 |
| Return On Assets (%) | 10.14 | 11.78 | 8.48 | 2.66 | 2.07 |
| Long Term Debt / Equity (X) | 0.06 | 0.12 | 0.31 | 1.21 | 1.09 |
| Total Debt / Equity (X) | 0.12 | 0.30 | 0.74 | 1.69 | 1.76 |
| Asset Turnover Ratio (%) | 1.31 | 1.83 | 2.13 | 1.42 | 1.50 |
| Current Ratio (X) | 1.83 | 1.23 | 1.02 | 1.13 | 1.05 |
| Quick Ratio (X) | 1.28 | 0.84 | 0.67 | 0.47 | 0.45 |
| Inventory Turnover Ratio (X) | 4.47 | 5.93 | 5.89 | 3.32 | 3.88 |
| Interest Coverage Ratio (X) | 15.21 | 6.70 | 5.19 | 2.19 | 2.10 |
| Interest Coverage Ratio (Post Tax) (X) | 11.09 | 5.00 | 3.81 | 1.63 | 1.60 |
| Enterprise Value (Cr.) | 132.59 | 0.00 | 0.00 | 0.00 | 0.00 |
| EV / Net Operating Revenue (X) | 1.26 | 0.00 | 0.00 | 0.00 | 0.00 |
| EV / EBITDA (X) | 8.97 | 0.00 | 0.00 | 0.00 | 0.00 |
| MarketCap / Net Operating Revenue (X) | 1.32 | 0.00 | 0.00 | 0.00 | 0.00 |
| Price / BV (X) | 2.53 | 0.00 | 0.00 | 0.00 | 0.00 |
| Price / Net Operating Revenue (X) | 1.32 | 0.00 | 0.00 | 0.00 | 0.00 |
| EarningsYield | 0.07 | 0.00 | 0.00 | 0.00 | 0.00 |
Strength and Weakness
| Strength | Weakness |
|---|---|
|
|
Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Hemant Surgical Industries Ltd:
- Net Profit Margin: 9.27%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: 23.37% (Industry Average ROCE: 29.8%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: 17.86% (Industry Average ROE: 25%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): 11.09
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 1.28
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 14.8 (Industry average Stock P/E: 14.8)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 0.12
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: 9.27%
About the Company - Qualitative Analysis
Medical Equipment & Accessories
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| 502, 5th Floor, Ecstasy Business Park Co-Op Socteiy Limited, Mumbai Maharashtra 400080 | Mr. | Hanskumar%20Shamji%20Shah Chairman%20&%20Managing%20Director |
| Management | |
|---|---|
| Name | Position Held |
| Mr. Kaushik Hanskumar Shah | WholeTime Director & CFO |
| Mr. Hemant Praful Shah | Whole Time Director |
| Mrs. Nehal Babu Karelia | Non Executive Director |
| Mrs. Pooja Kirti Kothari | Independent Director |
| Mr. Sourabh Ajmera | Independent Director |
FAQ
What is the latest intrinsic value of Hemant Surgical Industries Ltd?
The latest intrinsic value of Hemant Surgical Industries Ltd as on 27 December 2024 is ₹209.83, which is 63.93% higher than the current market price of ₹128.00. The stock has a market capitalization of 134 Cr. and recorded a high/low of 225/115 during the current fiscal year 2024-2025. As of Sep 2024, the company has reserves of ₹48 Cr and total liabilities of ₹116 Cr.
What is the Market Cap of Hemant Surgical Industries Ltd?
The Market Cap of Hemant Surgical Industries Ltd is 134 Cr..
What is the current Stock Price of Hemant Surgical Industries Ltd as on 27 December 2024?
The current stock price of Hemant Surgical Industries Ltd as on 27 December 2024 is 128.
What is the High / Low of Hemant Surgical Industries Ltd stocks in FY 2024-2025?
In FY 2024-2025, the High / Low of Hemant Surgical Industries Ltd stocks is 225/115.
What is the Stock P/E of Hemant Surgical Industries Ltd?
The Stock P/E of Hemant Surgical Industries Ltd is 14.8.
What is the Book Value of Hemant Surgical Industries Ltd?
The Book Value of Hemant Surgical Industries Ltd is 55.6.
What is the Dividend Yield of Hemant Surgical Industries Ltd?
The Dividend Yield of Hemant Surgical Industries Ltd is 0.00 %.
What is the ROCE of Hemant Surgical Industries Ltd?
The ROCE of Hemant Surgical Industries Ltd is 29.8 %.
What is the ROE of Hemant Surgical Industries Ltd?
The ROE of Hemant Surgical Industries Ltd is 25.0 %.
What is the Face Value of Hemant Surgical Industries Ltd?
The Face Value of Hemant Surgical Industries Ltd is 10.0.
